Lipocine to present at h.c. wainwright 26th annual global investment conference

Salt lake city , aug. 27, 2024 /prnewswire/ -- lipocine inc. (nasdaq: lpcn), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that dr. mahesh v. patel, president and chief executive officer, will present and meet with investors at the h.c.
LPCN Ratings Summary
LPCN Quant Ranking